June Industries

Which are the latest news on June Industries?

What does June Industries do?

June Industries Ltd is a Micro Cap company in the Computers - Software & Consulting industry, incorporated in 1995, with recent quarterly net sales and profit reported as 0 Cr. The company has a market cap of INR 26 Cr and no significant financial metrics.

Overview:<BR>June Industries Ltd operates in the Computers - Software & Consulting industry and is categorized as a Micro Cap company.<BR><BR>History:<BR>The company was incorporated on 20th February 1995 and was formerly known as Jindal Online.Com Limited. The latest quarterly results reported net sales and net profit of 0 Cr for the period ending March 2026.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 0 Cr (Quarterly Results - Mar 2026) <BR>Most recent Net Profit: 0 Cr (Quarterly Results - Mar 2026) <BR>Market-cap value: INR 26 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>Industry P/E: N/A <BR>Dividend Yield: 0.00% <BR>Debt Equity: 0.00 <BR>Return on Equity: 0.00% <BR>Price to Book: 0.00<BR><BR>Contact Details:<BR>Address: Pushpawati Building No2 II Flr, Chandanwadi Girgaon Road Mumbai Maharashtra : 400002 <BR>Email: investor.relations@jindalonline.com <BR>Website: http://www.kashyaptele-medicines.com

Who are in the management team of June Industries?

The management team of June Industries includes Amit Agrawal (Managing Director), Surabhi Agrawal, Amrita Khetan, Raghav Agrawal (Directors), Devkinandan Sharma, Mayank Khetan (Independent Directors), and Paritosh Trivedi (Company Secretary & Compliance Officer).

The management team of June Industries includes the following individuals:<BR><BR>1. Amit Agrawal - Managing Director<BR>2. Surabhi Agrawal - Independent Director<BR>3. Amrita Khetan - Director<BR>4. Devkinandan Sharma - Independent Director<BR>5. Raghav Agrawal - Director<BR>6. Mayank Khetan - Independent Director<BR>7. Paritosh Trivedi - Company Secretary & Compliance Officer<BR><BR>If you need more details about any specific member or their roles, feel free to ask!

Who are the peers of the June Industries?

June Industries' peers include Infonative Solutions, Starcom Info, Accedere, and Benchmark Comp., among others. In terms of management risk, Infonative Solutions and Globtier Infotec are rated excellent, while Benchmark Comp. has the highest 1-year return at 24.02%, and Accedere has the lowest at -31.32%.

Peers: June Industries' peers are Infonative Solu., Starcom Info., Accedere, Globtier Infotec, Benchmark Comp., Mudunuru, Micropro Softwar, Yudiz Solutions, Mindpool Tech., and Quicktouch Tech.<BR><BR>Quality Snapshot: Excellent management risk is observed at Infonative Solu. and Globtier Infotec, while Average management risk is found at Quicktouch Tech. Below Average management risk is noted at Accedere, Benchmark Comp., Mudunuru, Micropro Softwar, Yudiz Solutions, and Mindpool Tech. Growth is Average at Infonative Solu., Accedere, and Mindpool Tech., while Below Average growth is seen at Globtier Infotec, Benchmark Comp., Mudunuru, Micropro Softwar, Yudiz Solutions, and Quicktouch Tech. Good capital structure is present at Infonative Solu., Accedere, Globtier Infotec, Benchmark Comp., Mindpool Tech., and Quicktouch Tech, while Average capital structure is noted at Micropro Softwar and Below Average at Mudunuru and Yudiz Solutions.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Benchmark Comp. at 24.02%, while the lowest is Accedere at -31.32%. June Industries' own 1-year return is -29.66%, which is better than Accedere but worse than Benchmark Comp. Additionally, several peers including Globtier Infotec, Mudunuru, Accedere, and Yudiz Solutions have negative six-month returns.

How has been the historical performance of Kashyap TeleMed.?

Kashyap TeleMed has shown stable but low net sales, remaining at 0.19 Cr for the last two years, with total operating income mirroring this trend. The company has struggled with profitability, reporting a break-even in Mar'25 after previous losses, and earnings per share have remained at 0.0, indicating ongoing financial challenges.

Answer:<BR>The historical performance of Kashyap TeleMed shows a relatively stable but low level of net sales over the years, with figures remaining at 0.19 Cr in both Mar'25 and Mar'24, and slightly higher at 0.20 Cr in Mar'23, Mar'22, and Mar'19. The total operating income has mirrored the net sales, remaining at 0.19 Cr in Mar'25 and Mar'24, while also being 0.20 Cr in the previous years. The company has not incurred any raw material costs, purchase of finished goods, or power costs during this period. Employee costs have increased from 0.05 Cr in Mar'17 to 0.11 Cr in Mar'25, indicating a gradual rise in operational expenses. However, total expenditure (excluding depreciation) peaked at 0.30 Cr in Mar'22 before decreasing to 0.19 Cr in Mar'25. Operating profit has fluctuated, with a loss of 0.03 Cr in Mar'24 and a break-even point in Mar'25, while profit before tax has remained at 0.00 Cr in Mar'25 and Mar'23, with a loss of 0.03 Cr in Mar'24. The profit after tax has also been stagnant, showing a loss of 0.03 Cr in Mar'24 and no profit in the subsequent years. The earnings per share have remained at 0.0 in Mar'25, reflecting the company's ongoing challenges in achieving profitability. <BR><BR>Breakdown:<BR>Kashyap TeleMed's financial performance has been characterized by consistent but low net sales, which have remained stable at 0.19 Cr for the last two years, with a slight increase to 0.20 Cr in the years prior. The company's total operating income has followed a similar trend, indicating no significant growth. Employee costs have gradually increased, suggesting a rise in operational expenses, while total expenditure has seen a notable decrease from 0.30 Cr in Mar'22 to 0.19 Cr in Mar'25. Despite these changes, the company has struggled with profitability, reporting an operating profit of 0.00 Cr in Mar'25 after a loss in the previous year, and consistently low profit before and after tax figures. The earnings per share have not improved, remaining at 0.0 in Mar'25, which reflects the ongoing difficulties in achieving financial stability and growth.

When is the next results date for Kashyap TeleMed.?

Kashyap TeleMed will announce its results on 12 November 2025.

Kashyap TeleMed is scheduled to declare its results on 12 November 2025.

How big is Kashyap TeleMed.?

As of 24th July, Kashyap Tele-Medicines Ltd has a market capitalization of 38.00 Cr, classifying it as a Micro Cap company, with recent net sales of 0.20 Cr and a net loss of 0.01 Cr over the latest four quarters. Data for shareholder's funds and total assets is unavailable.

As of 24th July, <BR><BR>Market Cap: Kashyap Tele-Medicines Ltd has a market capitalization of 38.00 Cr, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 0.20 Cr. The sum of Net Profit for the latest 4 quarters shows a loss of 0.01 Cr.<BR><BR>Balance Sheet Snapshot: The reporting period is the latest annual period. However, data for Shareholder's Funds and Total Assets is unavailable.

Who are the top shareholders of the Kashyap TeleMed.?

The top shareholders of Kashyap TeleMed are Jindal Worldwide Limited with 31.25%, Amitara Industries Private Limited with 19.01%, and individual investors holding 30.92%. There are no pledged promoter holdings, and the company is not held by mutual funds or foreign institutional investors.

The top shareholders of Kashyap TeleMed include Jindal Worldwide Limited, which holds the largest stake at 31.25%. Following that, Amitara Industries Private Limited is the highest public shareholder with a 19.01% stake. Additionally, individual investors collectively hold 30.92% of the company. Notably, there are no pledged promoter holdings, and the company is not held by any mutual funds or foreign institutional investors.

Why is Kashyap TeleMed. falling/rising?

As of 10-Jun, Kashyap Tele-Medicines Ltd's stock price is declining at 8.05, down 1.95%, with a total drop of 16.23% over the last nine days. Despite strong historical returns, recent trends show weakened investor confidence and significant underperformance compared to the broader market.

As of 10-Jun, Kashyap Tele-Medicines Ltd is experiencing a decline in its stock price, currently at 8.05, which represents a decrease of 0.16 or 1.95%. The stock has been underperforming, having fallen consecutively for the last nine days, resulting in a total decline of 16.23% during this period. Additionally, the stock's performance today has underperformed its sector by 3.42%. Despite a strong year-to-date return of 183.45% and a one-year return of 253.07%, the recent trend indicates a significant drop in investor participation, with delivery volume falling by 92.81% compared to the five-day average. There are no positive or negative dashboard factors available to provide further context on the stock's recent movement.<BR><BR>In the broader market context, the stock's short-term performance over the past week shows a decline of 9.35%, contrasting sharply with the Sensex, which has gained 2.05% during the same period. This underperformance relative to the benchmark suggests that investor sentiment towards Kashyap Tele-Medicines Ltd has weakened, contributing to its recent price decline. While the stock has historically shown strong returns, the current trend indicates challenges that may be affecting investor confidence.

What is the technical trend for Kashyap TeleMed.?

As of December 27, 2024, Kashyap TeleMed's technical trend is bullish, supported by positive MACD and moving averages, although caution is advised due to a bearish monthly RSI signal.

As of 27 December 2024, the technical trend for Kashyap TeleMed has changed from mildly bullish to bullish. The weekly MACD is bullish, supporting the positive trend, while the daily moving averages also indicate a bullish stance. The KST is bullish on both weekly and monthly time frames. However, the monthly RSI shows a bearish signal, which suggests some caution. The Bollinger Bands are mildly bullish on both weekly and monthly charts. Overall, the current technical stance is bullish, with strength primarily driven by the MACD and moving averages, despite the bearish signal from the monthly RSI.

Has Kashyap TeleMed. declared dividend?

No Dividend History Available